Screening of FVIII inhibitors in hemophilia a patients using the modified Bethesda assay in the west of Algeria

被引：0
|
作者：
Benlaldj, D. [1 ]
Moulasserdoun, K. [2 ]
Rahal, C. [2 ]
Seghier, F. [2 ]
机构：
[1] Univ Hosp Ctr Oran, Dept Haemobiol, Oran, Algeria
[2] Ctr Hosp Oran, Dept Haemobiol, Oran, Algeria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-521
引用
收藏
页码：684 / 684
页数：1
相关论文
共 50 条
  • [21] General decrease of circulating microparticles is related to the presence of FVIII inhibitors in hemophilia A patients
    Chaves, D.
    Silveira, A.
    Moreira, M.
    Bela, S.
    Araujo, H.
    Teixeira-Carvalho, A.
    Campos-Nunes, F.
    Martins-Filho, O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 382 - 382
  • [22] The rapid Bethesda assay is equivalent to the standard Bethesda assay for detection of factor IX inhibitors in patients with severe haemophilia B
    Sahud, Mervyn
    Zhukov, Olga
    Naides, Stanley J.
    Serrano, Cynthia
    Wong, Edward
    Dlott, Jeffrey
    Racke, Frederick
    HAEMOPHILIA, 2020, 26 (04) : 735 - 740
  • [23] Low detection rate of antibodies to non-functional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay
    Ling, M
    Duncan, EM
    Rodgers, SE
    Street, AM
    Lloyd, JV
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (12) : 2548 - 2553
  • [24] GENERAL DECREASE OF CIRCULATING MICROPARTICLES IS RELATED TO THE PRESENCE OF FVIII INHIBITORS IN HEMOPHILIA A PATIENTS
    Silveira Cassette, A.
    Moreira, M.
    Bela, S.
    Araujo, H.
    Teixeira-Carvalho, A.
    Campos-Nunes, F.
    Chaves, D.
    Martins-Filho, O.
    HAEMATOLOGICA, 2015, 100 : 306 - 307
  • [25] Experience with a modified Nijmegen-Bethesda method for measurement of inhibitors in hemophilia patients: The CDC inhibitor surveillance pilot project.
    Miller, Connie H.
    Platt, S. Jean
    Abshire, Thomas
    Brettler, Doreen
    Brockenstedt, Paula
    DiPaola, Jorge
    Massey, Gita
    Neff, Anne
    Shapiro, Amy
    Tarantino, Michael
    Wicklund, Brian
    Creary, Melissa
    Soucie, J. Michael
    BLOOD, 2007, 110 (11) : 350A - 350A
  • [26] Immune Tolerance Induction Therapy for Patients With Hemophilia A and FVIII Inhibitors Particularly Using Low-Dose Regimens
    Lin, Pei-Chin
    Liao, Yu-Mei
    Tsai, Shih-Pien
    Chang, Tai-Tsung
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1029 - 1033
  • [27] Beyond the Bethesda Assay-Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles
    Livnat, Tami
    Dunn, Amy
    Azar-Avivi, Shirley
    Cox, Courtney
    Avishai, Einat
    Meeks, Shannon L.
    Kenet, Gili
    BLOOD, 2014, 124 (21)
  • [28] Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII
    Hooimeijer, Louise H.
    Stein-Wit, Marjet A.
    Voskuilen, Marja A. J.
    Lukens, Michael, V
    Meijer, Karina
    Makelburg, Anja B. U.
    Tamminga, Rienk Y. J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [29] FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors
    Hofbauer, Christoph J.
    Kepa, Sylvia
    Schemper, Michael
    Quehenberger, Peter
    Reitter-Pfoertner, Sylvia
    Mannhalter, Christine
    Reipert, Birgit M.
    Pabinger, Ingrid
    BLOOD, 2016, 128 (02) : 293 - 296
  • [30] Induction of Immune Tolerance to Canine FVIII in Hemophilia a Dogs with Inhibitors Using AAV-Mediated Expression of Canine FVIII
    Finn, Jonathan D.
    Sabatino, Denise E.
    Ozelo, Margareth C.
    Zhou, Shangzhen
    Lillicrap, David
    Kazazian, Haig H.
    Nichols, Timothy C.
    Arruda, Valder R.
    BLOOD, 2008, 112 (11) : 96 - 96
12345